Inflammatory bowel diseases (IBD) consist of two primary phenotypes, Crohn’s disease (CD) and ulcerative colitis (UC). Despite advances in medical treatment in IBD, disease-associated or IBD surgery-associated complications (such as strictures and fistulas) are common. Interventional IBD or therapeutic endoscopy has an expanding role in the treatment of disease and surgical complications. Endoscopic therapy offers more effective than medical treatment and less invasive than surgery, for the management of IBD-associated structural complications. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, and post-surgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stricturoplasty, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, endoscopic mucosal resection, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD will become an integrated part of the multidisciplinary approach for patients with complex IBD. This is a joint venture of Columbia University Irving Medical Center, NewYork Presbyterian Hospital, and the Global Interventional IBD Group. This CME-accreted conference will use “the Columbia Interventional IBD Symposium” as a logo from now on. It will run a full-day Zoom-based conference on January 14-15, 2022.
- Discuss familiarity with the current status of biological therapy in IBD
- Define principles, indications, techniques, and outcomes of endoscopic therapy for strictures, fistulae, and surgical leaks in IBD
- Identify familiar with principles, diagnosis, and
management of colitis-associated neoplasia in IBD
- Discuss familiarity with rescue strategies for endoscopy-associated complications
This program has been designed for regional, national, and worldwide audiences, including gastroenterologists, inflammatory bowel disease specialists, GI endoscopists, colorectal surgeons, general surgeons, GI pathologists, GI radiologists, NP/PA/RN in gastroenterology, IBD, and colorectal surgery, stoma nurses, medical students, medical/surgical residents, GI/colorectal fellows.
In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 8.50 AMA PRA Category 1 Credits™ for completing this activity.
The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Method of Participation
You will receive a confirmation email before the event with instructions for joining via Zoom.